EpiTherapeutics' Acquisition

EpiTherapeutics was acquired by Gilead Sciences on May 06, 2015.

EpiTherapeutics is developing novel innovative cancer drugs based on the world leading research in epigenetics conducted by Professor Kristian Helin and his group at Biotech Research & Innovation Cent…

Articles about EpiTherapeutics' Acquisition: